Back

Including the social and environmental implications to left ventricular assist device transitions of care

19 May 2017 (18:07 - 18:18)
Organised by:
Congress Presentation Part of: Clinical case session Psycho-social ACNAP Premium Access EuroHeartCare 2017

About the speaker

Photo
Assistant Professor Jackeline Iseler

Michigan State University, East Lansing (United States of America)

5 More presentations in this session

Presentation thumbnail
Elderly patient with atrial fibrillation, treated with oral anticoagulants
Ms K. Lomper (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
When to stop- end of life issues in a 36 year old GUCH(grown up congenital heart) patient.
Ms E. Laws (Pisa, IT)
Abstract Slides
Presentation thumbnail
Can the prize of the perfect body be heart breaking?
Ms E. Cronin (Clonmel, IE)
Abstract Slides
Presentation thumbnail
24/7 telephone support after discharge for surgical aortic valve replacement as a potential lifesaving intervention -a clinical case from the AVRre study
Mr S. Danielsen (Oslo, NO)
Abstract Slides
Presentation thumbnail
Perioperative inappropriate ICD shocks in response to electromagnetic interference: could this be avoided with a correct mangement of the patient?

Access the full session

Session thumbnail
Clinical case session

The Event

Event poster

EuroHeartCare 2017

19 May 2017 18:07 CET
You may be interested in
thumbnail
Congress Presentation
The lived experience of patients with left ventricular assist devices: a systematic review of qualitative studies
25 August 2023
thumbnail
Webinar
Transition of care to prevent recurrence after acute coronary syndrome: 100 days after discharge
7 December 2022
thumbnail
Congress Presentation
Left ventricular assist devices as bridge-to-transplantation in a low organ donor environment
22 May 2023
thumbnail
Congress Session
Therapeutic dilemmas in patients with left ventricular assist device (LVAD)
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources